| PRD_900059 | Name: | [(2R,3S,4S,5S)-2,5-bis(hydroxymethyl)-5-[(2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4-oxidany
l-oxolan-3-yl] [(2R,3R,4S,5S)-2,4,5-tris(oxidanyl)oxan-3-yl] hydrogen phosphate | Formula: | C17 H31 O18 P | Description: | oligosaccharide with Phosphate connecting between monosaccharides | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900061 | Name: | DIHYDRO-ACARBOSE | Formula: | C25 H45 N O18 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900072 | Name: | CELLOOCTAOSE | Formula: | C48 H82 O41 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900126 | Name: | Blood group A Lewis B antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900127 | Name: | Blood group A Lewis Y antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900128 | Name: | Blood group A Lewis Y antigen, alpha anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_001133 | Name: | (2R,6S,13aR,14aR,16aS)-6-{[(cyclopentyloxy)carbonyl]amino}-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate | Formula: | C37 H51 N5 O9 S | Definition date: | 2013-08-07 | Last modified: | 2020-07-20 |
|
| PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
| PRD_002368 | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-10-02 | Last modified: | 2019-10-02 |
|
| PRD_002333 | Name: | Pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002335 | Name: | Linear precursor of pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002331 | Name: | Chymostatin A (bound form) | Formula: | C31 H43 N7 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
| PRD_002303 | Name: | [(3-{(3S,6S,9S,15R,20aS)-15-[(N-acetyl-L-phenylalanyl)amino]-3-(cyclohexylmethyl)-6-[(1H-indol-3-yl)methyl]-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-9-yl}propyl)amino](amino)methaniminium | Formula: | C47 H66 N11 O7 | Definition date: | 2018-05-30 | Last modified: | 2018-05-30 |
|
| PRD_001186 | Name: | Myosin-A, stapled peptide | Formula: | C97 H175 N31 O23 S | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | Definition date: | 2013-11-06 | Last modified: | 2017-12-15 |
|
| PRD_002230 | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | Formula: | C48 H81 N12 O18 P | Definition date: | 2016-05-04 | Last modified: | 2017-12-15 |
|
| PRD_001137 | Name: | (4S,6aR,7aS)-5-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]octahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4-carboxamide | Formula: | C30 H43 N5 O4 | Definition date: | 2013-08-28 | Last modified: | 2017-09-14 |
|
| PRD_001138 | Name: | (3S,7R,8aR)-2-{(2S)-2-(4,4-difluorocyclohexyl)-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-7-ethoxyoctahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C31 H45 F2 N5 O5 | Definition date: | 2013-08-07 | Last modified: | 2017-09-14 |
|
| PRD_001139 | Name: | (3S,8aR)-2-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C30 H45 N5 O3 | Definition date: | 2013-08-07 | Last modified: | 2017-09-14 |
|
| PRD_001141 | Name: | (3S,8aR)-N-((R)-chroman-4-yl)-2-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C29 H43 N5 O4 | Definition date: | 2013-08-28 | Last modified: | 2017-09-14 |
|
| PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
| PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_002089 | Name: | (1R,2S,19S,22R,34S,37R,40S,52S)-2-{[(2R,3S,4R,5R,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-amino-5,15-dichloro-64-({(2R,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(8-methylnonanoyl)amino]tetrahydro-2H-pyran-2-yl}oxy)-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-{[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2~3,6~.2~14,17~.2~19,34~.1~8,12~.1~23,27~.1~29,33~.1~41,45~.0~10,37~.0~46,51~]hexahexaconta-3,5,8(64),9,11,14,16,23(61),24,26,29(60),30,32,41(57),42,44,46,48,50,62,65-henicosaene-52-carboxylic acid (non-preferred name) | Formula: | C88 H97 Cl2 N9 O33 | Definition date: | 2014-09-10 | Last modified: | 2014-09-10 |
|
| PRD_001162 | Name: | Salinamide A | Formula: | C51 H69 N7 O15 | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | Definition date: | 2014-05-21 | Last modified: | 2014-05-21 |
|